Reagan-Udall, Pfizer Testing Ways To Tap Sentinel Network Without FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
A pilot project operated by the Reagan-Udall Foundation and funded by Pfizer will evaluate ways drug companies can use FDA’s Sentinel electronic data network to conduct independent post-market safety surveillance.